Prazosin Hydrochloride
Prazosin is an alpha-blocker that causes a decrease in total peripheral resistance and is used to treat hypertension. Prazosin is marketed by Pfizer and was initially approved by the FDA in 1988 It belongs to the class of drugs known as alpha-1 antagonists Label.
Systematic name
2-[4-(furan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
Therapeutic category
Anti-hypertensive
Available formulations
Solid